Single-Cell analysis Market worth 3.35 Bn USD by 2021

Monday 18 April 2016, Amsterdam

The report, now available on ASDReports, "Single-Cell Analysis Market by Product (Beads, Microplate, Reagents, Flow Cytometer, Microscope, Spectrophotometer), Cell Type (Human, Animal), Technique (NGS, PCR), Application (Cancer, Neurology, NIPD, IVF, CTCs) & End User - Global Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the single-cell analysis market along with the estimates and forecasts of the revenue and market share analysis.

The global single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion in 2016 at a CAGR of 18.2% from 2016 to 2021.  The single-cell analysis market is witnessing high growth due to factors such as increasing government funding for research, high prevalence of infectious diseases, expanding biotechnology and biopharmaceutical industries, and growth potential in single-cell sequencing.

The report segments this market based on product, cell type, technique, application, end-users, and regions. Among the various product, the consumables segment is expected to account for the largest share of the market. The consumables market includes beads, microplates, reagents and assay kits, and other consumables. Assay kits are further classified into immunoassays and cell-based assays.  Beads segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of beads segment can be attributed to the growing demand for magnetic beads in T-cell and stem cell research, HIV pathogenesis, advanced cancer research and modified drug delivery during medical treatment.

On the basis of Cell type, the single-cell analysis market is segmented into human cells, animal cells, and microbial cells. The human cells segment is expected to account for the largest share of the global single-cell analysis market in 2016. Rising incidence of diseases such as cancer is the key factor propelling the growth of this market.

On the basis of technique, the single-cell analysis market is segmented into flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), microscopy, mass spectrometry, and others techniques. The flow cytometry segment is expected to account for the largest share of the global single-cell analysis market in 2016. Technological advancements and increase in the conferences and symposiums are the key factors propelling the growth of this market.

On the basis of application, the single-cell analysis market is segmented into research applications and medical applications. Research applications further classified into Cancer, Immunology, Neurology, Stem cell, and others. Medical applications further classified into Noninvasive prenatal diagnosis, In vitro fertilization, and Circulating tumor cells (CTCs). The research applications segment is expected to account for the largest share of the global single-cell analysis market in 2016. Recent advances in single-cell technologies, and increase in the incidences of incidences of infectious diseases such as HIV are the key factors propelling the growth of this market.

End-users, included in the single-cell analysis market are academic & research laboratories, biopharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and cell banks and IVF centers. The academic & research laboratories segment is expected to account for the largest share of the global single-cell analysis market in 2016. Growth in funding for life science research, increasing number of medical colleges and universities are driving the growth of this market.

Based on regions, the global single-cell analysis market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as expansion of pharmaceutical and biotechnology industries, the adoption of genomic platform and high-content screening technology by research laboratories in North America.

Key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (U.S.)., Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.),), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), and Illumina, Inc.(U.S.).